AD1
IBTCMi003-A
General
Cell Line |
|
| hPSCreg Name | IBTCMi003-A |
| Alternative name(s) |
AD1
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
LBi002-A (PH-BL-002 Clone 2, iLB-272bfs2) Donor's gene variants: CD33, CD33, CD33, CD33 Donor diseases: Alzheimer disease LBi002-B (PH-BL-002 Clone 9, iLB-272bfs9) Donor's gene variants: CD33, CD33, CD33, CD33 Donor diseases: Alzheimer disease LBi004-A (PH-BL-204 Clone 210, iLB-278bfs210) Donor's gene variants: CD33, CD33, CD33, CD33 Donor diseases: Alzheimer disease LBi004-B (PH-BL-204 Clone 211, iLB-278bfs211) Donor's gene variants: CD33, CD33, CD33, CD33 Donor diseases: Alzheimer disease |
| Last update | 18th April 2022 |
| User feedback | |
Provider |
|
| Generator | Institute of Basic Theory for Chinese Medicine (IBTCM) |
| Owner | Institute of Basic Theory for Chinese Medicine (IBTCM) |
| Distributors | |
| Derivation country | China |
External Databases |
|
| BioSamples | SAMEA14096092 |
| CLO | CLO_0103852 |
| Cellosaurus | CVCL_C1Q0 |
| Wikidata | Q114311694 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
| Disease associated phenotypes |
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA14096093 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
| Alternatives to consent are available? | No |
| Is there other documentation provided to the donor for consenting purposes? | No |
| Confirm that consent was obtained by a qualified professional | Yes |
| Has the donor agreed to be re-contacted? | Unknown |
| Has the donor been informed about how her/his data will be protected? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | Controlled Access |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | The ethics committee of Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences |
| Approval number | 2018EC-KY-007 |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
| Source cell type |
renal epithelial cell |
| Source cell origin |
UrineThe fluid that is excreted by the kidneys. It is stored in the bladder and discharged through the urethra.
Synonyms
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Is reprogramming vector detectable? |
No |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
ReLeSR™ from STEMCELLTechnologies
|
| Medium |
mTeSR™ 1
|
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SSEA-4 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
Score:
| Marker | Present | Absent |
| mCpG | ||
| OCT4 |
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46, XX
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.